Efficacy of Individualized Homoeopathic Medicines for Migraine among adults; Double blind, Randomized, Placebo controlled Clinical Trial

one0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年8月2日

试验速览

暂无简介。

•1. Subjects who has diagnosed as per the International classification of Headache disorders diagnostic criteria - 3 for Migraine.
•2. Subjects will be selected irrespective of their sex, socio-economic status and occupation.
•3. Age between 18 to 50 years.
•4. If the subject is illiterate then the relatives or family members will be assessed to fill the headache diary.
•5. Subjects who are willing to participate and sign the written informed consent form.

•1. Subjects suffering from the complications of migraine.
•2. Suspected secondary headache (trauma, headache attributed to vascular or non vascular intracranial disorders, medication overuse headache, hypertension).
•3. Subjects are undergoing treatment with non-steroidal anti inflammatory drugs (NSAIDS), antiemetic, triptans, ergot alkaloids and oestrogen during 2 weeks prior to enrollment in the study.
•4. Subjects suffering from uncontrolled systemic illness or psychiatric diseases and/or life-threatening infections.
•5. Substance abuse and/or dependence.
•6. Pregnant or lactating women.
•7. Subjects already undergoing homoeopathic treatment elsewhere for any chronic disease within last 02 months.
•8. Non-compliance to the study treatment/ protocol.

发起方